Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You liked last year when an unrelated Company/Geron jacked ACT from 2 cents to $0.294? yeah we all did. However this time Around Advanced Cell technology will be the CENTER of the upcoming Storm and IMO unlike Geron Corp ACT will actually start the FIRST human P-1/2 for Stem Cell Clinical for the FDA EVER.
1,000% gain from these levels.
Tungsten Carbide Strong and Back to the Big Bang LONG.
thanks Rocky.
http://www.imn.ie/index.php/current-issue/news/2919-uk-stem-cell-doctor-charged-with-misconduct
Dr Trossel’s clinic, which was reportedly supplied by another firm, Advanced Cell Therapeutics (ACT), since banned in the Netherlands over fears of the safety of the treatment, at one point started providing the treatment at the Cork Road Medical Centre in Carrigaline, before the intervention of the Irish Medicines Board (IMB).
It is a "Margie Chassman" Company bro.
BUY everything that she is in. everything. These "people" are professioanl Grifters. They are the people that Washtrade stocks to high levels. these are the SCUM of the WALLSTREET. the Original Pump and Dump Penny promoters.
well that would make my 1st post tio you null and void would it not.
how bout a .9999 for every 1 share? easy to get rid of the mystical shorts/
A forward split would certainly allow, once and for all, to settle the shorts' debate.
REALLY, that is the ONLY thing HUH, that could settle the SO CALLED Company {followers} position that a short position exits?
How about this? Call Chet in the Miami office and make a FORMAL Complaint to the SEC.
How bout, the Auditors whom have been working on the HTDS and Mellow Hope financials since 9/3/09 ACTUALLY provide ONE 10q?
How bout HTDS/Mellow Hope ACTUALLY PROVIDE A PHOTOCOPY/Independent Verifiable 3rd Party EVIDENCE of its existence? Like a bill of laidin, import export license etc etc etc etc
A Forward split for a Stock under A Short Position is disasterour for shareholder value. It will/would quickly go to .0001 and cellar boxing would prevent it from ever getting out. But that would be fine with the SCAM ARTISTS running the show right? I mean they dont care if they sell shares at .01 or .0001 it is ALL free money.
STOCK IS A SCAM.
thanks Rocks. Your hard-drive of knowledge is greatly appreciated.
Well I guess my memory was correct and IMO if ACT does grow its science into meaningful revenue. The CommonShareholders will receive the "class action law suit" lawyers calling cards inviting them to sue. That link proves that the Company is not operating in a sound Stewardship of Company Treasury IMO.
This "greasing" of the financial wheels is nothing new to wallstreet.
thanks again.
With all the potential good things in the hopper right now I hope this BS doesn't deter anything.
It wont right now IMO. But it may be a class action law suit in the making with "common shareholders" once the Company is actually worth something. Rocky, u could probably bring it up faster than I could. but I remember last Feb/March when ACT paid 5million to GET 5Million,? am I wrong about that?
IMO all these Bond Holders control Caldwell to an extent. When the Company paid out 250million shares for a million dollars in debt this seemed very suspect to me. THIS was the best they could do? Granted it was the credit crisis. But this was the Best they could do? Was Caldwell and Rabin "greasing" the financial skids for future monies to be lent? Whom are these Offshore accounts? IMO they are affiliated with the Bond Holders. It is all very shadey business and Your dead on, I hope it does not interfer with the science.
O/S-the one that matters-2,844,387,312 shares issued and outstanding.
I disagree somewhat, although an O/S is good to know.
it also matters that if Margie converts here warrants that number goes to 15billion o/s.
IMO ride this wave upcoming, a very likely pump soon, and a very likely merger as well wiping out the sheeple.
IMO SCLL will get merged shortly and under go a massive R/S swap etc with a New Company.
It is NOT a typo. It is an easy premonition of an obvious upcoming merger with a lighter Company. You all will be wiped out soon. hope for the best and be quick to act IMO
that is about 3 of 48 Companys I have found she is in.
I figured after losing 80% of my IRA after the dotcom bust I could NOT beat "them" so I would just join "them". Well stop playing with charts and just follow the "Trash" that control Us sheeple. that is what I do. yes I dicker with my fav's , but for the most part, I am like a garbage man following the "trash"
GL
the stock is primed for a pump. ole Margie knows.
http://www.investors.com/NewsAndAnalysis/Article.aspx?id=106538148&source=Newsfeed
MED NYSE
this company traded for 27 cents a share in 2001 MED is involved/accussed of fraud and is being investigated. wow big surprise.
Due your research on these SCAM artists. You can make alot of money. I have been drawing the Web that these people weave ALL day. Anything that they invest in is on top to bust out. I can not figure out where SCLL plays in,. but IMO I would anticipate a Merger with one of the other SCAM Companys they have?
Just So You All Know the TRASH Your Dealing with when investing in a "Margie" Company. After her hubby was convicted of securities fraud for Playing the MM game of WashTrading he was forbidden to have ANYTHING to do with any kind of association with Holding stock in Any companys etc. But apparently his wife has gained a great deal of investment knowledge? wow must be the Stem Cells. Anyway, do a Google search as I did months ago. I have 2.7 million shares of this SCAM stock that I bought this month as I prepared for the upcoming PUMP Ole Mr. Blech will orchestrate in 2010. this stock is a buy, but it does pay to know whom YOUR dealing with.
www.sec.gov/Archives/edgar/data/1175151/0001144204-08-0 - [Cached Version]
Published on: 11/18/2008 Last Visited: 11/19/2008
Margie Chassman is married to David Blech.
...
Mr. Blech disclaims beneficial ownership of these shares. Since 1980 Mr. Blech has been a founder of companies and venture capital investor in the biotechnology sector. His initial venture investment, Genetic Systems Corporation, which he helped found and served as treasurer and a member of the board of directors, was sold to Bristol Myers in 1986 for $294 million of Bristol Myers stock. Other companies he helped found include DNA Plant Technology, Celgene Corporation, Neurogen Corporation, Icos Corporation, Incyte Pharmaceuticals, Alexion Pharmaceuticals and Neurocrine Biosciences. He was also instrumental in the turnaround of Liposome Technology, Inc. and Biotech General Corporation. In 1990 Mr. Blech founded D. Blech & Company, which, until it ceased doing business in September 1994, was a registered broker-dealer involved in underwriting biotechnology issues. In May 1998, David Blech pled guilty to two counts of criminal securities fraud, and, in September 1999, he was sentenced by the U.S. District Court for the Southern District of New York to five years' probation, which was completed in September 2004. Mr. Blech also settled administrative charges by the Commission in December 2000 arising out of the collapse in 1994 of D. Blech & Co., of which Mr. Blech was President and sole stockholder. The settlement prohibits Mr. Blech from engaging in future violations of the federal securities laws and from association with any broker-dealer. In addition, the District Business Conduct Committee for District No.10 of NASD Regulation, Inc. reached a decision, dated December 3, 1996, in a matter styled District Business Conduct Committee for District No. 10 v. David Blech, regarding the alleged failure of Mr. Blech to respond to requests by the staff of the National Association of Securities Dealers, Inc. ("NASD") for documents and information in connection with seven customer complaints against various registered representatives of D. Blech & Co. The decision found that Mr. Blech failed to respond to such requests in violation of NASD rules and that Mr. Blech should, therefore, be censured, fined $20,000 and barred from associating with any member firm in any capacity. Furthermore, Mr. Blech was discharged in bankruptcy in the United States Bankruptcy Court for the Southern District of New York in March 2000.
Delistings, Withdrawals and Enforcement Proceedings - [Cached Version]
Published on: 8/12/2001 Last Visited: 9/19/2002
The suspensions were based upon the entry of a judgment by the United States District Court for the Southern District of New York in SEC v. David Blech, et al., 99 Civ.4770 (RWS), on January 31, 2002, in which the District Court enjoined both Silverman and Prodani from violating Section 17(a) of the Securities Act of 1933, Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5.
...
From approximately June through September 1994, David Blech, the chief executive officer of D. Blech & Co., orchestrated a massive manipulative scheme designed to increase or stabilize the prices of a number of the biotechnology securities for which D. Blech & Co. was a market maker.
...
As part of this scheme, David Blech routinely sold biotechnology stocks from D. Blech & Co.'s inventory accounts to brokerage accounts that Blech controlled that were in the names of other individuals and entities.These controlled accounts then sold the biotechnology stocks back to the brokerage firm or to other accounts controlled by David Blech.These trades created the appearance of active trading in the biotechnology stocks.Additionally, through this trading, Blech was able to reduce D. Blech & Co.'s inventory position in the biotechnology stocks, yet still artificially withhold from the market the supply of the biotechnology stocks.
...
Additionally, Prodani, who was the registered representative for various customer accounts at the broker-dealer, executed purchases and sales in those accounts at David Blech's direction without consulting the account holders. [SEC v. David Blech, Alefheim Prodani and Richard Silverman, C.A.
all health service stock will pop sooner than you know
trust me
I am interested in what You have to say and mean by the statement above. what is your opinion?
thx
IMO That is the way this stock trades. up and then a crash. IMo it is indicitive of dilution and smart trders whom cut and run instead of holding so as to fight another day. easy for me to say though when holding at much lower pps.
The stock will have a ginormous pop in 2010 as will ALL Stem Cell related Companys.
GLTA
Post Unavailable
Additional Information
Post Unavailable
Additional Information
Post Unavailable
Additional Information
http://www.ustream.tv/recorded/3933270
http://groups.google.com/group/advanced-cell-technology/browse_thread/thread/437f4586ec6294da?hl=en
medone conference with CEO presentation. 1/12/2010
In my mind there is still a remote chance this company is AOK (don't laugh!! Please?).
LMAO AHAHAHAHAHAHAHAHAHAHAHAHAHHAAHAHAH, sorry nano. that was funny.
BTW the Company is a Scam, ALL of my emails to various government authoritys ie. China, India, Chile have turned up nothing. India's is the most flagrant IMO of a lie in that the email replys are written back in English spot on grammar etc and India has No idea whom MellowHope is.
The Company is a scam and outright SCAM. nothing but a PinkfinkySCAM stock that preys upon the single moms', factory worker, elderly and or similar.
today was by far the Clearest example of a Standard "Pinky" press releases.
The old Naked Short Trick!!
Yep! it is ALWAYS the Naked Shorts in Pinky Land, all the bashers work for the Naked Shorts. always the evil MM's, or that PsDotCom is "in on it" Our Auditors are working on Our Financials, A One time dividend is Coming! Just You all wait til we get to the bottom of the this Evilshorts, We have a merger a coming with an OTC-BB, Constant Ambiguous Lanaguage, Share Buy backs!, Did I miss something? The Ole-Pinky Handbook
Company is a SCAM
Dew,
HTDS IS A SCAM as 99.99% of ALL Pinksheets Companys are. Sell Stock, Do a Massive Reverse Split and start over again.that is the S.O.P. No audited financials will EVER be seen by this Company EVER. No Share Buy Back, No Stem Cell Company, nothing and NADDA. i forecast a Pump for this soon? but I am all done with this one, the technicals have changed and most likely due to the washtrading stopping?
Check this page once a day for NEW Companys. You see a .0001? You buy as much as You can. I have a few other GREAT pumps I know of like this, but it is off topic for the board.
http://www.minamargroup.net/our_clients.html
So, what kind of PR will take this to .10 ?
ANYTHING to Do with the Stem Cell Industry. It can be unrelated as it was last year with Geron Corp receiving the go ahead to Conduct a Human P-1.
It will have to be a Major Milestone as this. I made a fortune this time last year on the entire market and most likely will do so again in 2010.
BTW Sheeple does NOT mean new investor. It means someone that is easily led and does NO DD on his/her own. Trading stock is NOT rocket science, it is DD, common sense and tech's.
Hope that helps.
The Company is on a Pump. The whole Stem Cell biotech is as well for 2010. The sheeple know nothing of market cap or the likes. Ride the wave instead getting oobered by it.
http://sumfolio.com/cord-blood-america-a-bet-on-stem-cell-research-147/
Cord Blood America: A Bet on Stem Cell Research
Written on Tuesday, January 12th, 2010 by Rick Telfur
Cord Blood America Inc. (OTC:CBAI) may not be your average business model for a medical stock, but growth in stem cell research and the company’s ambitious expansion plans make it worth a second look!
Cord Blood America Inc. (CBAI) collects, tests, processes and preserves umbilical cord blood for use in future stem cell therapy. As of October 2009, the company offers blood banking services to all 50 states and realizes a one-time enrollment fee as well as annually recurring storage and maintenance fees.
The company’s business model is based on the uniform belief that stem cells will play a key role in fighting disease in the future. And umbilical cords contain a rich store of stem cells that have already been used to treat 75 diseases, including leukemia, severe anemia, metabolic blood disorders and immune deficiencies.
Recently, the company’s move to de-emphasize its legacy radio and advertising business, along with the overall sluggish economy, has led to a sharp drop in revenues and net income. However, many investors believe that recent growth initiatives, geographic diversification and a recovering economy will help drive improved results in subsequent quarters.
A Solid Growth Strategy for 2010
Cord Blood America recently completed investor-friendly capital-raising over the past 18 months, in the amount of $16.8 million. The new capital comes in the form of lines of credit, meaning that it does not dilute shareholder value nor create any immediate balance sheet obligations. The company plans to use the capital for several initiatives:
“We intend to continue our organic growth in this business through continued improvement of internal processes, continued improvement and expansion of our relationships with health insurance providers, and through continuing efforts to leverage those relationships in the pregnancy programs with those providers.
“We also plan to build additional sales channels through obstetrics and gynecological practices and other healthcare professionals, hospitals and other health care influencers. We also hope to leverage our growth through mergers and/or acquisitions of other stem cell preservation companies.”
Source: 10-Q Filing from the SEC
The company noted in a recent press release that the funds themselves would be used to grow through acquisitions. While this can be a somewhat risky way to leverage up and expand, it can pay big dividends to investors if the business takes off and stem cells become a necessity in everyday life to treat diseases.
Stem Cell Research is a Near-term Catalyst
Stem cell research has begun to gain momentum after the Obama administration reinstituted government funding for the sector. In fact, stem cells have already been shown to be effective in treating mice, but the Food and Drug Administration has been a key roadblock, requiring expensive safety testing before human trials can be conducted.
Until now, this has meant spending a lot of money that simply wasn’t available for such a risky technology that was unproven. But with Obama’s repeal of the anti-stem cell research regulation, new funding is flowing into the sector that should fast-track these studies and stem cell research itself, thereby making Cord Blood America’s storage more necessary to the public.
One great example of this growth in funding was from the California Institute for Regenerative Medicine, which recently provided $18 million in state funding for stem cell research thanks to the state’s Proposition 71. Projects like this are helping to fill a void between being too commercial for federal funds and too risky for private investors.
Demand is also clearly seen in the public, with a growing number of people that even make a pilgrimage to China in order to receive stem cell injections that can help treat disease. Meanwhile, Canada already allows a few safe and proven stem cell therapies to be used to treat blood disorders like leukemia with bone marrow transplants and immune disorders.
The Takeaway…
¦Cord Blood America is positioning itself to be a leader in umbilical cord blood preservation with a strategy to grow organically and through acquisitions.
¦A revival in stem cell research and strong consumer demand could provide a key catalyst for the company moving forward.
¦Despite the upside, Cord Blood America remains a very risky investment given the controversy and limited research surrounding stem cell treatments.
yeah the PINKY SCAM is going up, but at what point? The resistance has been falling and falling for weeks now. A large buy at the end of a 25% red/dump is usual standard smart SOP for an investor, and that IMO is why you so that at .0029. btw it could have and most likely was from an MM.
The Stock is a SCAM, the Company lies in its press Release ie. 9/14/09 We have Been Approved by the SFDA for H1N1 manufacture. Wehave received a license. bla bla bla. This Pinky Scam fits all the usual Pinky play books, Promise Gret things coming soon! Our Auditors are working on Our financials, We are buying a Cutting edge Company /Stem Cell Company, Share Buy back and etc etc etc.
SCAM
been lurking for a while Locks. holding over 400k since $0.007 You and I both know that CBAI is ONE press release away from 10cents a share.
The PR from yesterday is huge. Hoping the 10q is kind when it comes to the 0/S. a Buy back would/will be huge. But I think the CEO is BUYING/Building the Company in 2010 and will condense in 2011. All is good though, in it for a 10bagger.
CBAI's press yesterday was huge and it has not hit the market yet IMO.
ALL Stem plays in 2010 will be profitable.
you shouldn't falsify information you get from pinksheets.com since there is NO unlimited authorized shares anywhere.
The information is off Your Pinky Mining Scam {I-Hub-Box}.
Always the Same with the {Pinkies} investors in these garbage Pinky Scams. 1/Paid Bashers 2/ Shorters 3/ Consortium of organized entity's with the MM's leading it these are always the reasons for a stocks failure.
Listen bro this stock is a scam, just another Pinky Mining Scam looking to drum up money. They do not care how many .0001's they sell. They know that someday if they actually have a viable source,. they will do a massive reverse split and wipe the {pinkies} investors out.
BTW I troll the PinkyScam Boards. I have found that doing saves usually saves 1 or 2 investors from being ripped off.
Good luck with your Pinky Mining Scam.
LONG AND STRONG!!!!!!!!!!!!!LMAO
Amazing. UNLIMITED AUTHORIZED SHARES. So it could have a "google" amount of shares? a One with a hundred zero's after it?
Assay results will be released as soon as the company receives them
How many Pinking Mining Scam Press releases have said that? LOL.
Just another Pinky Mining Scam IMO>
http://www.pinksheets.com/pink/quote/quote.jsp?symbol=tnri
OTC Market Tier
Pink Sheets No Information
Authorized - Unlimited
Free - 2,413,328,790
Restricted - 7,600,000,000
Issued & Outstanding - 10,013,328,790
Estimated Market Cap
$258,464 as of Jan 8, 2010
Outstanding Shares
861,546,413 as of Oct 20, 2008
Float(shares)
30,045,413 as of May 15, 2008
:: INSIDER TRADING WARNING
This company may not be making material information publicly available.
If you are an affiliate, employee, insider, or any person in possession of nonpublic material information about this company, please be advised that buying or selling this security may constitute trading "on the basis of" material nonpublic information prohibited under Section 10(b) of the Securities Exchange Act of 1934 and Rules 10b-5 and 10b5-1 thereunder. Violators of these laws are subject to civil and criminal penalties.
What is insider trading?
Illegal insider trading refers generally to buying or selling a security, in breach of a fiduciary duty or other relationship of trust and confidence, while in possession of material, nonpublic information about the security.
Rule 10b5-1 provides that a person trades on the basis of material nonpublic information if that person is "aware" of the material nonpublic information at the time of the purchase or sale.
Affiliates, insiders, relatives, or other persons in possession of material information should use extreme caution when buying or selling securities on the basis of material information, particularly in securities where the company is not making adequate current information publicly available as a matter of practice.
Why is Pink OTC displaying this warning?
Companies that are identified on pinksheets.com as having “No Information” may be placing their shareholders at risk of violating 10b5-1 insider trading rules. Pink OTC Markets recommends that investors wishing to place a trade in such securities contact the company to verify it is making adequate current information publicly available.
How can a company make material information publicly available?
•Companies can make material information publicly available by registering a class of their securities and making current reports with the SEC.
•Companies can make material information publicly available by qualifying under Rule 12g3-2(b) under the Exchange Act (“Rule 12g3-2(b)”).
•For companies that are not subject to SEC reporting requirements under 12(g) or 12(b) of the Act, Pink OTC Markets provides the Alternative Reporting Standard to facilitate the availability of adequate current information.
?Companies that post such information through the OTC Disclosure & News Service are able to conveniently and efficiently make their information publicly available on their quote page on www.pinksheets.com.
?The Alternative Reporting Standard is designed for companies to meet the minimum disclosure requirements under SEC Rules 15c211 and 144(b) and assist companies in protecting their affiliates from 10b5-1 violations. Companies are urged to seek the advice of experienced securities counsel regarding materiality and methods to make material information publicly available.
?For more information about the Alternative Reporting Standard, please visit our Alternative Reporting Standard page.
Note: Companies may choose to provide current information on their corporate websites. Pink OTC Markets encourages affiliates, employees, insiders, or any person in possession of nonpublic material information about a company to examine the company's corporate website for current information, if they are not able to find it through pinksheets.com or in current reports filed with the SEC, to ensure compliance with Rules 10b-5 and 10b5-1. However, the warning message on the company's quote page on pinksheets.com will continue to be displayed. To remove this warning message, the company must meet one of the three standards listed above.
For an overview of insider trading, visit the SEC’s website at sec.gov/answers/insider.htm.
IMO Bag Holders bailing. almost 1.3billion shares traded above .01 cent and a 75% plus loss is far to much to take?
Look at HTDS "New" Head of Stem Cell medicine in Europe!lmao. unverified, but Right up Miro's alley ehhh?
http://news.bbc.co.uk/2/hi/health/8452874.stm
Stem cell doctor Trossel denies charges at GMC hearing
Dr Trossel's case surrounds his offering of stem cell treatments to patients
A doctor offering controversial stem cell treatment to multiple sclerosis sufferers has denied charges at the General Medical Council (GMC) today.
Nine men and women consulted Dutch-trained Dr Robert Trossel in the 'desperate' hope they could get help, the GMC was told.
The prosecution said there was 'no evidence' that the substance injected into them contained stem cells.
Dr Trossel has denied charges relating to all nine of the patients.
The GMC was told that in the majority of cases, the treatment administered by Dr Trossel had 'no effect' on their condition.
'Wholly unscientific'
Tom Kark, counsel for the GMC said the patients were 'vulnerable' and facing a future "likely to be characterised by further deterioration and cumulative disability".
His methods and treatment, while very costly, appear to have been wholly unscientific
Tom Kark, GMC lawyer
"The GMC case against Dr Trossel is that his purported use of the therapy and the way that he went about it with these patients was wholly illegitimate, misleading and dishonest and there is considerable doubt that he was in fact using the appropriate stem cells at all.
"His methods and treatment, whilst very costly, appear to have been wholly unscientific."
The GMC heard that the nine patients involved - James McCorrisken, Malcolm Fear, Stephen Murphy, Anita Knowles, Rebecca Parker, Catherine Neal, Tracy Wagstaff, Karen Galley and Deborah Sandford - are all willing to be identified.
It is alleged that Dr Trossel injected a substance said to contain stem cells into all but two of them.
Mr Kark said: "Large sums of money, in many cases raised from donations and sponsored events, were forwarded to Dr Trossel or his associates by these individuals in the desperate hope that this treatment would lead to some marked improvement in their health."
Dr Trossel denies a series of charges relating to all nine of the patients including acting in a way that is inappropriate and exploitative of vulnerable patients.
The GMC was also told Dr Trossel had received a five-month prison sentence suspended for three years and a fine of 4,000 euros after being convicted in a Belgian court of two offences relating to stem cell treatment between October 2006 and January 2007.
The GMC suspended Dr Trossel in 2007. Although he was not struck off at that stage, he was not allowed to practise as a doctor.
It will be HARD and fast when it does come.
thanks Repair.
But I am a new comer compared to the Mod's on this board. They are the tireless that have all the knowledge on this SCAM.
I had to jump out AGAIN on this one for a small loss AGAIN. Four small loss' in a row for me, but the gains in 2009 were substantial.
It is not trading like it was and the signals are mixed. the volume is also falling off on a daily basis. Going to have to rest for a while till I can determine a pattern in this one.
The standard Pinky Play book with the upcoming gigantic dilution is to let it drop some more IMO and then Washtrade it up and up, build a strong "Pinky-shareholder" base that can defend the garbage the company puts out then the Company will take it farther with a verifiable 3rd party Pr to get it to the hump so that the dilution can take place IMO.
anyway good luck and never be fooled again. 99.99% of Pinksheets Companys are SCAMS, out and out SCAMS. 98.99% OTC-BB companys are SCAMS as well run by those that had money to Buy a trading-Shell and infuse a few hundred thousand dollars to articially cause volume interests and then put out bullsh!t press releases filled with lies and inverifiable information. It is legalized Grand Larceny playing out everyday in MainStreet USA.
IMO you have time to load up in the 8's and 9's if the Company comes out with nothing of scientific interest this month.
IMO Buy as many as you can stand to lose and then buy some more. Do not be discouraged by this upcoming week of trading or for that matter January's/Feb trading. This is a good play for 2010.
Nice Repair. A HUGE Pump is coming my good man, and it will be MUCH higher than one cent. as we all know or well some of Us know 2.5BILLION shares will slam into the market in March 2010. flip and flip
it has received notification from the US Food and Drug Administration (FDA) that the Agency is currently drafting a response to the Company relating to the Investigational New Drug (IND) Application it filed in November seeking clearance to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt’s Macular Dystrophy (SMD). ACT is currently on clinical hold pending a response from the Agency, which it expects within the next few weeks.
http://www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&newsId=20100108005231&newsLang=en
HAHAHa Nice Rocky.
The Sheeple are easily led and thus are VERY easily confused.
I hope and Pray that a Reverse Split of 30-1 is on tap for 2010. To get rid of the Pennypeople and also get to a more visible exchange. I look at Broke biotechs in the Amex etc with not even half as much in the pipe line with 200-600million outstanding trading at 2bucks a share and shake my head.
BTW Your impartial postings offer good knowledge of "FACTS" on a given situation. Keep posting Facts.
Dont let the Pennypeople keep you from posting. You have a fantastic and equalled take on this Company that myself and "hundreds" appreciate.
Company said in 10-Q It was due to be notified about progression by end of december by the PRC. could be a 300% pps Pr gainer coming.
Have a good weekend fellow morgue attendants.